With the rapidly declining costs of next-generation sequencing, whole-genome sequencing (WGS)is more accessible than ever for cancer research. While the coding genome has been well-characterized, the non-coding regions—over 98% of the genome—remain largely unexplored,despite their critical roles in gene regulation and disease progression. This seminar will explore the untapped potential of the non-coding genome for biomarker discovery and cancer biology. We’ll discuss how leveraging these vast regions can reveal novel drivers of cancer, offering new insights and opportunities for precision medicine in an era of affordable WGS.
Registration: https://us02web.zoom.us/meeting/register/tZcrcemtqjovGN0SAx2dLcGT_RMD0eloXGTh#/registration